EurekAlert: Why Some People May Not Respond to the Malaria Vaccine

Creating protective immunity against the early liver stage of malaria infection is feasible, but has been difficult to achieve in regions with high rates of malaria infection. Many current malaria vaccines target the pre-erythrocytic stage of infection in the liver, however in endemic regions, increased blood stage exposure is associated with decrease vaccine efficacy, challenging current malaria vaccine efforts. 

Teaching Moments: An Interview with David Townes

David Townes, UW associate professor of medicine (emergency medicine), joined the UW faculty in 2001. He is also a public health and medical technical advisor to the Office of Foreign Disaster Assistance at USAID and a medical epidemiologist in the Emergency Response and Recovery Branch at the Centers for Disease Control and Prevention (CDC). Throughout his career Townes has worked in Antarctica, Costa Rica, Ethiopia, Ghana, Guatemala, Haiti, Indonesia, Jordan, Kenya, Malawi, Mozambique, Nepal, Russia, Senegal, Tanzania, Turkey, the West Indies and Zambia.

KOMO: Local Research Could Cure Zika Virus and the Common Cold

By Molly Shen

SEATTLE -- On the heels of the World Health Organization declaring a public health emergency related to the Zika virus, local scientists said they are already working on a cure. And if they're able to treat Zika, it could also mean a cure for viruses ranging from West Nile to Ebola, to the common cold.

Scientists at biotech company Kineta and the University of Washington are developing the compound. Just like antibiotics treat bacterial infections, their antiviral drug would fend off a range of viruses.

Pages